Compounds > tazobactam
Page last updated: 2024-09-03

tazobactam and Pneumonia

tazobactam has been researched along with Pneumonia in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (9.52)18.2507
2000's5 (23.81)29.6817
2010's7 (33.33)24.3611
2020's7 (33.33)2.80

Authors

AuthorsStudies
DePestel, DD; DeRyke, CA; Garrison, MW; Harris, KA; Moise, PA; Pfaller, MA; Sader, HS; Shortridge, D1
Carvalhaes, CG; Castanheira, M; Sader, HS; Shortridge, D1
Huang, Y; Xu, Y; Zhang, Y1
Arends, SJR; Carvalhaes, CG; Castanheira, M; Mendes, RE; Sader, HS; Shortridge, D1
Kalil, AC; Zavascki, AP1
Flamm, RK; Pfaller, MA; Shortridge, D; Streit, JM1
Adedoyin, A; Caro, L; De Waele, JJ; Gadzicki, E; Kuti, JL; Larson, KB; Nicolau, DP; Rhee, EG; Yu, B; Zeng, Z1
He, A; He, L; Qian, Y1
Chiang, TT; Chiu, CC; Lin, TC; Wu, RX; Yang, YS1
Goodlet, KJ; Nailor, MD; Nicolau, DP1
Huntington, JA; Miller, BW; Nicolau, DP; Xiao, AJ1
Greene, S; Kailainathan, R; Koutsogiannis, Z; Wong, A1
Dong, M; Gong, C; Huang, F; Jiao, Y; Li, AH; Li, MZ; Luo, M; Zhang, TG1
Clarke, MJ; Edwards, SJ; Wordsworth, S1
Dittrich, P; Maier, A; Matzi, V; Nuhsbaumer, S; Pinter, H; Pinter, J; Smolle, J; Smolle-Jüttner, FM; Tomaselli, F; Woltsche, M1
Bevin, SV; Broadberry, RE; Farren, TW; Garratty, G; Kohler, JA; Poole, J; Skidmore, I; Yates, S1
Leitner, E; Lode, H; Schmitt, DV; Welte, T1
Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G1
Coia, JE; Gillespie, TA; Hanson, MF; Johnson, PR; Notman, AW1
Chen, Y; Gao, L; Hou, F; Li, J1
Cassone, M; Falcone, M; Paris, A; Pavoni, G; Pistella, E; Venditti, M1

Reviews

1 review(s) available for tazobactam and Pneumonia

ArticleYear
[Piperacillin-tazobactam in the treatment of severe nosocomial infections].
    Recenti progressi in medicina, 2002, Volume: 93, Issue:3

    Topics: Bacteria; beta-Lactamase Inhibitors; Clinical Trials as Topic; Costs and Cost Analysis; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Tazobactam

2002

Trials

5 trial(s) available for tazobactam and Pneumonia

ArticleYear
Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia.
    The Journal of antimicrobial chemotherapy, 2020, 06-01, Volume: 75, Issue:6

    Topics: Anti-Bacterial Agents; Cephalosporins; Critical Illness; Humans; Lung; Pneumonia; Tazobactam

2020
Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia.
    Journal of clinical pharmacology, 2016, Volume: 56, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cephalosporins; Cross Infection; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Penicillanic Acid; Pneumonia; Tazobactam; Young Adult

2016
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
    Infection, 2006, Volume: 34, Issue:3

    Topics: Adult; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Penicillanic Acid; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam; Treatment Outcome

2006
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11

    Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam

1998
A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Chinese medical journal, 1998, Volume: 111, Issue:11

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli Infections; Female; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Respiratory Tract Infections; Tazobactam; Ticarcillin; Urinary Tract Infections

1998

Other Studies

15 other study(ies) available for tazobactam and Pneumonia

ArticleYear
Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015-2018.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 112

    Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States

2021
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022, Volume: 41, Issue:2

    Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; Imipenem; Jupiter; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2022
Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections.
    Journal of medical virology, 2022, Volume: 94, Issue:12

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bunyaviridae Infections; Coinfection; Humans; Microbiota; Minocycline; Phlebovirus; Piperacillin; Pneumonia; Retrospective Studies; Severe Fever with Thrombocytopenia Syndrome; Tazobactam; Voriconazole

2022
Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021).
    International journal of antimicrobial agents, 2023, Volume: 61, Issue:4

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Hospitals; Humans; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2023
Can ceftolozane-tazobactam treat nosocomial pneumonia?
    The Lancet. Infectious diseases, 2019, Volume: 19, Issue:12

    Topics: Cephalosporins; Cross Infection; Double-Blind Method; Humans; Meropenem; Pneumonia; Tazobactam

2019
Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015-2017) Pseudomonas aeruginosa isolates from a global surveillance programme.
    Journal of global antimicrobial resistance, 2020, Volume: 21

    Topics: Asia; Cephalosporins; Europe; Female; Global Health; Humans; Latin America; Male; Microbial Sensitivity Tests; North America; Pacific Islands; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Public Health Surveillance; Sepsis; Skin Diseases, Bacterial; Tazobactam

2020
Imipenem-resistant Pseudomonas aeruginosa treated with piperacillin/tazobactam in a patient with severe pneumonia: a case report and related literature review.
    Annals of palliative medicine, 2021, Volume: 10, Issue:1

    Topics: Aged; Female; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Tazobactam

2021
Recurrence of Cytomegalovirus Viremia Causing Gastrointestinal Tract Bleeding at Different Sites in an Immuno-competent Patient.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:6

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Transfusion; Colitis; Colon; Cytomegalovirus; Cytomegalovirus Infections; Diarrhea; Esomeprazole; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Humans; Immunocompetence; Male; Penicillanic Acid; Piperacillin; Pneumonia; Pulmonary Disease, Chronic Obstructive; Steroids; Tazobactam; Treatment Outcome; Viremia

2017
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin

2017
Recognition of gamma-hydroxybutyric acid withdrawal: Rapid progression and prolonged symptomatology.
    Emergency medicine Australasia : EMA, 2017, Volume: 29, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Australia; Baclofen; Benzodiazepines; Diazepam; Humans; Hydroxybutyrates; Male; Penicillanic Acid; Phenobarbital; Piperacillin; Pneumonia; Psychomotor Agitation; Substance Withdrawal Syndrome; Sweating; Tazobactam; Tremor

2017
A Pneumonia Case Associated with Type 2 Polio Vaccine Strains.
    Chinese medical journal, 2017, 01-05, Volume: 130, Issue:1

    Topics: Ambroxol; Anti-Bacterial Agents; Humans; Infant; Male; Penicillanic Acid; Pneumonia; Poliomyelitis; Tazobactam; Vaccines

2017
Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2012, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cost-Benefit Analysis; Critical Care; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Markov Chains; Meropenem; Middle Aged; Models, Economic; Penicillanic Acid; Piperacillin; Pneumonia; Quality-Adjusted Life Years; Tazobactam; Thienamycins; Treatment Failure; United Kingdom

2012
Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
    British journal of clinical pharmacology, 2003, Volume: 55, Issue:6

    Topics: Adult; Aged; Area Under Curve; Enzyme Inhibitors; Female; Humans; Lung; Male; Microdialysis; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Sepsis; Tazobactam

2003
Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells.
    Transfusion medicine (Oxford, England), 2004, Volume: 14, Issue:1

    Topics: Adolescent; Adsorption; Anemia, Hemolytic; beta-Lactamase Inhibitors; Cell Survival; Coombs Test; Erythrocytes; Humans; Immunoglobulin G; Male; Penicillanic Acid; Pneumonia; Tazobactam

2004
Eradication of a resistant Pseudomonas aeruginosa strain after a cluster of infections in a hematology/oncology unit.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6, Issue:3

    Topics: Bacteremia; Cross Infection; Drug Resistance, Multiple; Enzyme Inhibitors; Hospitals, General; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Oncology Service, Hospital; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sanitary Engineering; Scotland; Species Specificity; Sputum; Tazobactam

2000